ICER Evaluates Cost-Effectiveness of ATTR-CM Treatments
New Screening Method for Early Preeclampsia Shows Promising Results in Catalonia
Medicare Set to Include COPD Drugs in Next Round of Price Negotiations, ICER Prepares Evaluation
ICER to Assess New Treatment for Retinitis Pigmentosa
ICER Draft Report Evaluates Treatment for EBV+ PTLD
August 2024 Milestones for Institute for Clinical and Economic Review
ICER Publishes Evidence Report on Transthyretin Amyloid Cardiomyopathy Treatments
ICER Report Highlights Pricing Concerns for Imetelstat in Myelodysplastic Syndrome Treatment
July 2024 Milestones for Institute for Clinical and Economic Review
Assessing the Value of Suzetrigine for Acute Pain
Chronic Obstructive Pulmonary Disease: ICER Evaluates Ensifentrine’s Effectiveness and Value
ICER Publishes Evidence Report on Anemia Treatment in Myelodysplastic Syndrome
Post-Traumatic Stress Disorder Treatment Lacks Sufficient Evidence for MDMA-Assisted Psychotherapy
June 2024 Milestones for Institute for Clinical and Economic Review